- Investor's Business Daily•last year
The European Union's medical advisory committee endorsed several key drugs from leading stocks Friday, making EU approval likely for some potential blockbusters: • The Committee for Medicinal Products ...
- Investor's Business Daily•2 years ago
Top-rated specialty drugmaker Horizon Pharma beat first-quarter sales estimates and settled a patent suit, but its stock fell 6% to 27.62 on Friday. Horizon's (HZNP) earnings excluding one-time items rose ...
Requested symbol wasn't found
NasdaqGS . Currency in USD
Add to watchlist
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|